Premier Biomedical Inc's Customers Performance

Name: Premier Biomedical Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

BIEI

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


BIEI's Source of Revenues		During the corresponding time, Premier Biomedical Inc saw a revenue deteriorated by -85.63 % year on year, sequentially revenue fell by -62.31 %. While revenue at the Premier Biomedical Inc's corporate clients • List of BIEI Customers

for the same period Premier Biomedical Inc revnue deteriorated by -85.63 % year on year, sequentially revenue fell by -62.31 %.

• List of BIEI Customers

Premier Biomedical Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Premier Biomedical Inc's Comment on Sales, Marketing and Customers

News about Premier Biomedical Inc Contracts

The Convergence of Minds A Triumvirate for Advanced Graphene Solutions in the Service of Ballistic Protection

In a momentous conjunction of industrious intellect and scientific innovation, the esteemed entities of Premier Graphene Inc. HGI Industrial Technologies, and Defense Atomics have entered into an alliance of strategic significance. This partnership heralds a new epoch in the realm of advanced materials science, particularly pertaining to the utilitarian applications of graphene in the arena of ballistic protection.Graphene, that most wondrous allotrope of carbon, has garnered the admiration of the learned circles for its remarkable properties. It is acclaimed as the lightest, strongest, and most conductive of all known materials, thus presenting a plethora of prospective applications that transcend the bound...

Exploring the Revolutionary Potential of Graphene Enhanced Concrete: A Collaborative Breakthrough between Premier Graphene, Inc. and HGI Industrial Technologies in Mexico

In recent years, the field of graphene research has witnessed remarkable advancements due to its extraordinary properties and potential applications in various industries. Among these industries, the pharmaceutical and construction sectors are experiencing a noteworthy synergy in their efforts to harness the unique capabilities of graphene. Premier Graphene, Inc., formerly known as Premier Biomedical Inc. (OTC: BIEI), has announced a groundbreaking collaboration with HGI Industrial Technologies S.A de P.I in Mexico. Together, they aim to revolutionize the construction industry with their pioneering Graphene Enhanced Concrete (GEC). In this article, we explore the significance of this partnership and delve in...

BIEI's Stock Performance relative to it's Customers

BIEI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Premier Biomedical Inc	0.07	0.01	-0.37	-
SUBTOTAL	0.00	0.00	0.00	-

Sources: Premier Biomedical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Premier Biomedical Inc’s corporate clients.
For your research, we’ve provided 9 tables on Premier Biomedical Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.